Growth Metrics

CytomX Therapeutics (CTMX) Depreciation and Depletion (2016 - 2017)

CytomX Therapeutics (CTMX) has disclosed Depreciation and Depletion for 2 consecutive years, with $400000.0 as the latest value for Q4 2017.